Next Article in Journal
Facile Preparation of N-Glycosylated 10-Piperazinyl Artemisinin Derivatives and Evaluation of Their Antimalarial and Cytotoxic Activities
Next Article in Special Issue
Anomeric O-Functionalization of Carbohydrates for Chemical Conjugation to Vaccine Constructs
Previous Article in Journal
Effects of Linalyl Acetate on Thymic Stromal Lymphopoietin Production in Mast Cells
Previous Article in Special Issue
Recent Advances in Toll Like Receptor-Targeting Glycoconjugate Vaccines
Article Menu
Issue 7 (July) cover image

Export Article

Open AccessFeature PaperReview
Molecules 2018, 23(7), 1712;

Recent Advances in the Synthesis of Glycoconjugates for Vaccine Development

Dipartimento di Chimica, Universita’ degli Studi di Milano, via Golgi 19, 20133 Milano, Italy
Author to whom correspondence should be addressed.
Received: 8 June 2018 / Revised: 9 July 2018 / Accepted: 11 July 2018 / Published: 13 July 2018
(This article belongs to the Special Issue Conjugate Vaccines from Carbohydrate Antigens)


During the last decade there has been a growing interest in glycoimmunology, a relatively new research field dealing with the specific interactions of carbohydrates with the immune system. Pathogens’ cell surfaces are covered by a thick layer of oligo- and polysaccharides that are crucial virulence factors, as they mediate receptors binding on host cells for initial adhesion and organism invasion. Since in most cases these saccharide structures are uniquely exposed on the pathogen surface, they represent attractive targets for vaccine design. Polysaccharides isolated from cell walls of microorganisms and chemically conjugated to immunogenic proteins have been used as antigens for vaccine development for a range of infectious diseases. However, several challenges are associated with carbohydrate antigens purified from natural sources, such as their difficult characterization and heterogeneous composition. Consequently, glycoconjugates with chemically well-defined structures, that are able to confer highly reproducible biological properties and a better safety profile, are at the forefront of vaccine development. Following on from our previous review on the subject, in the present account we specifically focus on the most recent advances in the synthesis and preliminary immunological evaluation of next generation glycoconjugate vaccines designed to target bacterial and fungal infections that have been reported in the literature since 2011. View Full-Text
Keywords: bacterial infections; fungal infections; carbohydrates; glycoconjugates; vaccines bacterial infections; fungal infections; carbohydrates; glycoconjugates; vaccines

Graphical abstract

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Colombo, C.; Pitirollo, O.; Lay, L. Recent Advances in the Synthesis of Glycoconjugates for Vaccine Development. Molecules 2018, 23, 1712.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top